ClinicalTrials.gg
Active, not recruitingNCT06679751ID-TOUCHUpdated Aug 19, 2026

Infectious Disease (ID) Testing OUtreach in Carceral Hubs

An observational study in HIV Infections and Opioid Use Disorder, sponsored by Boston Medical Center. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Boston Medical Center · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
59
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in HIV Infections by Boston Medical Center — none open to participants now, 1 under way, none of them phase 3. HIV Infections · Boston Medical Center.

Started
2025
the only one that year
Observational
5 of 19
none open now
Registered
19th of 19
by date

Among the 19 studies in HIV Infections by Boston Medical Center, this one is the only one that started in 2025, is one of 5 observational ones, and was the 19th registered.

HIV Infections

4,737 studies on the registry are indexed under HIV Infections; 247 are open to participants now.

Browse HIV Infections studies →

Open to participants now

None of the 19 studies in HIV Infections by Boston Medical Center is open now. The open studies under HIV Infections, anywhere →

Who these studies take

Of the 159 HIV Infections studies recruiting now, 104 (65%) set no upper age limit and 42 (26%) stop at 75 or younger; 31 take children under 18; 60 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 19 studies in HIV Infections by Boston Medical Center as a file.
02

Study summary

This pilot feasibility study represents part 3 of a larger R61 study, where the investigators will follow a cohort about their experiences with human immunodeficiency virus (HIV) testing.

This project aims to assess the effectiveness of an intervention at two jail sites in the Boston area: South Bay House of Corrections and Nashua Street Jail implemented in January of 2025 that is aimed at improving HIV testing practices and HIV treatment in those carceral facilities. This implementation was developed independently of the investigators' study activities. The jails worked to develop changes in their electronic health record to offer HIV testing at various points in their intake and physical exam process. HIV care was not well-integrated with the jails' existing intake and healthcare administration systems and medications for opioid use disorder (MOUD) program. The investigators will evaluate the intervention the jails developed to address these issues. The outcomes of interest are more implementation than effectiveness outcomes.

The primary goal of this study is to identify existing barriers in the carceral healthcare setting that prevent the improvement of HIV testing and treatment.

03

Conditions studied

  • HIV Infections
  • Opioid Use Disorder

Keywords

  • Carceral system
  • HIV testing
  • Pre-exposure prophylaxis (PrEP)
  • Justice Community Opioid Innovation Network (JCOIN)
  • End HIV Epidemic (EHE)
  • HIV Services
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals who are currently incarcerated in either South Bay Correctional Facility or Nashua Street Jail. To be considered eligible they must have opioid use disorder (OUD), be older than 18 years of age, and by self-report say that they will be released from the jail within about one month of the day of study enrollment.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Incarcerated at South Bay House of Corrections or Nashua Street Jail
  • Participant Report that they will be leaving jail within 1 month.
  • Participant must be comfortable speaking in the English Language
  • Has Opioid Use Disorder (OUD) indicated by participation in Medications for Opioid Use Disorder (MOUD) program and/or self-report

Exclusion criteria

Exclusion Criteria:

  • Cognitive ability that prevents obtained consent or completion of study activities (defined through Research Assistant (RA) determination)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
59 participants (actual)
Patient registry
No

Groups and cohorts

  • ID-TOUCH Program

    Participants will receive the ID-TOUCH intervention while incarcerated and meet with the study team three times for data collection: once before release, once one week after release, and once three months after release. Information collected will include: utilization of HIV services while in jail and while in the community and an exploration of self-reported high-risk behavior, perceived stigma and discrimination, and medical mistrust.

06

What researchers measure

Primary outcomes

  1. Number of participants that use HIV services while incarcerated

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. If there is any mention of HIV services of any type such as testing, obtaining information. or counseling related to HIV while incarcerated, the participant will be categorized as using HIV services/Yes.

    Time frame: on average 4-6 weeks

  2. Number of participants that use of PrEP if HIV negative

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. For participants who are HIV negative, if there is any mention of PrEP being used the participant will be categorized as using PrEP/Yes.

    Time frame: 1 week, 3 months post incarceration

  3. Number of participants that have HIV testing in the community if unknown status during incarceration

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants with unknown HIV status during incarceration who are tested for HIV in the community, will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

Secondary outcomes

  1. Number of participants that demonstrate HIV knowledge

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who demonstrate HIV knowledge will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

  2. Number of participants that have Risk Behaviors for HIV

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who have rsk behaviors for HIV will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

  3. Number of participants that have substance use

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who report they use substances \[eg smoking cigarettes, drinking alcohol, or using any illicit drugs\] will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

  4. Number of participants with Sexually Transmitted infections (STIs)

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who report that they were tested and told they have any STI other than HIV \[eg syphilis, gonorrhea, hepatitis C virus (HCV)\] will be categorized as Yes.

    Time frame: 1 month, 3 months post incarceration

  5. Number of participants with PrEP Awareness

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who demonstrate awareness about PrEP will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

  6. Number of participants with acute healthcare utilization

    This will be assessed from a review of information abstracted from study questionnaires and interviews with study staff and recorded as a binary 'Yes or No'. Participants who report they were either hospitalized or received care in an emergency room will be categorized as Yes.

    Time frame: 1 week, 3 months post incarceration

07

Study locations

1 site
  • South Bay House of Corrections
    Boston, Massachusetts 02118, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.

Of 187 non-industry observational studies under HIV Infections, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's planned 18 months is below that.

Counting every sponsor, half of 201 studies reached it within 38 months; a quarter within 16 and three quarters within 69.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2024
First posted
Nov 7, 2024
StartActual
Jun 23, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06679751
Collaborators
National Institute on Drug Abuse (NIDA), South Bay House of Corrections, Nashua Street Jail
Responsible party
Sponsor
First posted
Nov 7, 2024
Start date
Jun 23, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Aug 19, 2026

Study contacts

Alysse Wurcel, MD MS
principal investigator · Boston Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion